These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4123994)

  • 21. Animal models of the asthmatic state.
    Patterson R; Kelly JF
    Annu Rev Med; 1974; 25(0):53-68. PubMed ID: 4136527
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic value of the prick test and tissue RAST in allergic nasal polyposis].
    Philipp A; Koch T; Becker S; Soudah B
    HNO; 1991 May; 39(5):185-7. PubMed ID: 1874636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine.
    Tauber AI; Kaliner M; Stechschulte DJ; Austen KF
    J Immunol; 1973 Jul; 111(1):27-32. PubMed ID: 4123374
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of cyclic AMP in inhibiting the IgE-mediated release of histamine.
    Lichtenstein LM
    Ann N Y Acad Sci; 1971 Dec; 185():403-12. PubMed ID: 4107676
    [No Abstract]   [Full Text] [Related]  

  • 25. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.
    Creticos PS; Peters SP; Adkinson NF; Naclerio RM; Hayes EC; Norman PS; Lichtenstein LM
    N Engl J Med; 1984 Jun; 310(25):1626-30. PubMed ID: 6328300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro model of canine immediate-type hypersensitivity reactions.
    Krell RD; Chakrin LW
    Int Arch Allergy Appl Immunol; 1976; 51(6):641-55. PubMed ID: 63451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of histamine release from human leukocytes.
    Levy DA
    Ann Allergy; 1969 Oct; 27(10):511-8. PubMed ID: 4195891
    [No Abstract]   [Full Text] [Related]  

  • 28. Symposium on allergic lung disease. II. The late asthmatic responses.
    Hargreave FE; Dolovich J; Robertson DG; Kerigan AT
    Can Med Assoc J; 1974 Feb; 110(4):415 passim. PubMed ID: 4130351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Humoral mucosal immunity in allergic rhinitis].
    Kramer MF; Jordan TR; Pfrogner E; Rasp G
    Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological mediators in asthma.
    Townley RG
    Acta Allergol; 1974; 29 Suppl 11(0):15-25. PubMed ID: 4372844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reproduction of the anaphylactic reaction of isolated human smooth muscle organs and the effect of several adrenotropic substances].
    Poriadin GV; Baranov AP
    Biull Eksp Biol Med; 1975 Mar; 79(3):76-9. PubMed ID: 47769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP-induced inhibition of IgE-mediated hypersensitivity in human skin.
    Yamamoto S; Greaves MW; Fairley VM
    Immunology; 1973 Jan; 24(1):77-83. PubMed ID: 4119544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic diseases of the nose and middle ear in children.
    Miller DL; Friday GA
    Pediatr Ann; 1976 Aug; 5(8):482-98. PubMed ID: 60732
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
    Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical mediators of anaphylaxis (histamine, 5-HT, and SRS-A) released from horse lung and leukocytes in vitro.
    Burka JF; Deline TR; Holroyde MC; Eyre P
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):379-88. PubMed ID: 59377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of rabbit PCA reaction by drugs known to influence intracellular cyclic AMP.
    Kravis TC; Zvaifler NJ
    J Immunol; 1974 Jul; 113(1):244-50. PubMed ID: 4364952
    [No Abstract]   [Full Text] [Related]  

  • 38. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ; Austen KF
    Monogr Allergy; 1977; 12():189-97. PubMed ID: 335214
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of cellular anaphylaxis by beta-stimulants.
    Martin LE
    Postgrad Med J; 1971 Mar; 47():Suppl:26-30. PubMed ID: 4102079
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.